Login to Your Account



BIOPHARMA FIRMS POISED TO FLOAT?

Initial public offerings ban in China lifted, 2014 could be record year

By Alfred Romann
Staff Writer

Wednesday, January 8, 2014

HONG KONG – After a lost 2013, companies in China are expected to start issuing shares again this year and this could prove a boon to biopharmaceutical companies that are generally underrepresented in the markets in Shanghai and Shenzhen.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription